Groups | N | NBF (%) | P |
---|---|---|---|
Mean (SD) | |||
Control | 8 | 47.63 (5.01) | > 0.05a |
PRP-1 | 8 | 49.25 (7.38) | |
PRP-2 | 8 | 51 (8.8) | |
Control | 8 | 47.63 (5.01) | > 0.05b |
PRP-1 + PRP-2 | 16 | 50.13 (7.9) |
aNot statistically significant at level P < 0.05 (One-way ANOVA).
|
Groups | N | NBF (%) | P |
---|---|---|---|
Mean (SD) | |||
Control | 8 | 47.63 (5.01) | > 0.05a |
PRP-1 | 8 | 49.25 (7.38) | |
PRP-2 | 8 | 51 (8.8) | |
Control | 8 | 47.63 (5.01) | > 0.05b |
PRP-1 + PRP-2 | 16 | 50.13 (7.9) |
aNot statistically significant at level P < 0.05 (One-way ANOVA).
|